BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences.
Latest Ratings for EXAS
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Wells Fargo | Maintains | Equal-Weight | |
| Feb 2022 | Citigroup | Maintains | Neutral | |
| Feb 2022 | Raymond James | Maintains | Outperform |
